摘要
Glioblastoma (GBM) is identified to share common signal pathways between glioma and immune cells. Here, we find that T cell immunoglobulin domain and mucin domain protein 3 (TIM-3) is one of the most common co-inhibitory immune checkpoints in GBM shared by tumor and non-tumor cells. Glioma cell-intrinsic TIM-3 is involved in not only regulating malignant behaviors of glioma cells but also inducing macrophage migration and transition to anti-inflammatory/protumorigenic phenotype by a TIM-3/interleukin 6 (IL6) signal. In mechanism, as one of the major regulators of IL6, TIM-3 regulates its expression through activating NF-kB. Blocking this feedback loop by Tocilizumab, an IL6R inhibitor, inhibited the above effects and repressed the tumorigenicity of GBM in vivo. Our work identifies glioma cell- intrinsic functions of TIM-3/IL6 signal mediating the crosstalk feedback loop between glioma cells and tumor-associated macrophages (TAMs). Blocking this feedback loop may provide a novel therapeutic strategy for GBM.
学科与关键词
- Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?Tong, Ni; He, Zhenqiang; Ma, Yujie; Wang, Zheng; Huang, Ziming; Cao, Haihong; Xu, Lanyang; Zou, Yuheng; Wang, Wanyu; Yi, Chenpeng; Yin, Zhixin; Wang, Qirui*Frontiers in Cell and Developmental Biology, 2021, 9: 706286.被引 40
- LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarizationHu, Jinyang; Dong, Feng; He, You; Xia, Xianyou; Cheng, Fangling; Chen, Sui; Hou, Xiaoshuang; Zhang, Po; Liu, Guohao; Li, Ying; Gao, Qian; Dong, Minhai; Li, Ting; Li, Wei; Xiao, Qungen; Li, Xiaopeng; Yu, Xingjiang; Xi, Guifa; Guo, Dongsheng; Wu, Xudong*; Wang, Baofeng*Journal for ImmunoTherapy of Cancer, 2022, 10(9): e004452.被引 5
- PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastomaZhang, Hao; Wang, Yifan; Zhao, Yihan; Liu, Tao; Wang, Zeyu; Zhang, Nan; Dai, Ziyu; Wu, Wantao; Cao, Hui; Feng, Songshan; Zhang, Liyang; Cheng, Quan*; Liu, Zhixiong*CNS Neuroscience & Therapeutics, 2022, 28(11): 1748-1766.被引 11
